我院2008-2010年哮喘类疾病用药消耗分析

Consumption analysis of antiasthmatic drugs in our hospital during 2008-2010 period

目的了解我院哮喘类疾病临床用药情况及发展趋势,为临床合理用药提供参考。方法采用医院药库2008-2010年哮喘病治疗主要用药出库数据,从购药金额、用药频度(DDDs)等方面进行统计、分析用药特点。结果我院2008-2010年3年来哮喘类疾病购药金额和使用量呈上升趋势;购药金额按用药途径排名,第1位是吸入剂类哮喘用药;购药金额按种类排名,第1位是肾上腺皮质激素类药物;购药金额单项前3位药品为布地奈德混悬剂、沙美特罗替卡松吸入剂、孟鲁司特钠片剂;DDDs排名前3位药品为沙丁胺醇雾化溶液、沙美特罗替卡松吸入剂、孟鲁司特钠片剂。结论我院临床在哮喘类疾病用药方面基本符合支气管哮喘防治指南用药规范,总体用药种类及价格结构比较客观合理。

A/M To understand the current status and trend of drug use of asthma attack in our the hospital, and to supply the reasonable guide for clinical medication. METHODS The drug comumption data from the drug warehouse in the hospital for treatment of asthma during 2008 - 2010 period were used. Statistical analysis of drug characteristics from the araount of drug purchase, medication frequency （DDDs）, etc was performed. RESULTS From 2008 to 2010, the purchase amount and consumption of antiasthmatic drugs showed an upward trend. The purchase amount of drug ranking according to route of administration, the first was inhalants of asthma medication; according to types, the first was adrenal cortex hormone drugs. Consumption sum of individual top 3 drugs was budesonide suspension, salmeterol/fluticasone propionate inhalation and montelukast sodium tablets. DDDs ranking of the top 3 drugs for salbutamolum aerosol solution, salmeterol/fluticasone propionate inhalation and montelukast sodium tablets. CONCLUSION The clinical use in asthma disease medication is basically consistent with the prevention and treatment of bronchial asthma medication guide specification, overall medication type and price structure is more reasonable and objective.